Literatuur

  1. Glynne-Jones R et al. EXTRA ­a multicenter phase II study of chemo­radiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Int J Radiat Oncol Biol Phys. 2008;72(1):119-26
  2. Rao S et al. International rare cancers initiative multicenter randomized phase II trial of cisplatin and fluorouracil versus carboplatin and paclitaxel in advanced anal cancer: InterAAct. J Clin Oncol. 2020;38(22):2510-8

Richtlijnen

Ga naar de richtlijn Anuscarcinoom in de FMS richtlijnen­database.